Harnessing the Pancreatic Stem Cell

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 4, 2010, Pages 763-776

  Taylor Fishwick, David A ^a,b   Pittenger, Gary L ^a  

^a Strelitz Diabetes Center   (United States)

^b Department of Microbiology and Molecular Cell Biology ^*  (United States)

Author keywords

Beta cell mass; Differentiation; Embryonic stem cells; Pancreatic stem cell

Indexed keywords

ANTIDIABETIC AGENT; EPIDERMAL GROWTH FACTOR; EXENDIN 4; GASTRIN; GASTRIN DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE; INSULIN; ISLET NEOGENESIS ASSOCIATED PROTEIN; SAXAGLIPTIN; SITAGLIPTIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VILDAGLIPTIN;

ACINAR CELL; CELL DIFFERENTIATION; CELL DIVISION; CELL EXPANSION; CELL FATE; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL REGENERATION; CELL RENEWAL; CELL TRANSFORMATION; CELL TYPE; CLINICAL TRIAL; CYTOLOGY; DIABETES MELLITUS; DRUG MECHANISM; EMBRYONIC STEM CELL; ENDOCRINE CELL; EXOCRINE CELL; GLUCOSE BLOOD LEVEL; GRAFT VERSUS HOST REACTION; HORMONAL REGULATION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS CELL; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC DEVELOPMENT; EMBRYONIC STEM CELLS; FEMALE; HUMANS; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; PANCREAS; PREGNANCY; REGENERATIVE MEDICINE;

EID: 78649370010     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2010.08.008     Document Type: Review

References (100)

1. Ryan E.A., Lakey J.R., Paty B.W., et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002, 51(7):2148-2157.
2. Hainz U., Jürgens B., Heitger A. The role of indoleamine 2,3-dioxygenase in transplantation. Transpl Int 2007, 20(2):118-127.
3. Itakura S., Asari S., Rawson J., et al. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat. Am J Transplant 2007, 7(2):336-346.
4. Rehman K.K., Bertera S., Trucco M., et al. Immunomodulation by adenoviral-mediated SCD40-Ig gene therapy for mouse allogeneic islet transplantation. Transplantation 2007, 84(3):301-307.
5. Yang S.H., Jin J.Z., Lee S.H., et al. Role of NKT cells in allogeneic islet graft survival. Clin Immunol 2007, 124(3):258-266.
6. Pileggi A., Molano R.D., Ricordi C., et al. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 2006, 81(9):1318-1324.
7. Beck J., Angus R., Madsen B., et al. Islet encapsulation: strategies to enhance islet cell functions. Tissue Eng 2007, 13(3):589-599.
8. Hirshberg B., Rother K.I., Harlan D.M. Islet transplantation: where do we stand now?. Diabetes Metab Res Rev 2003, 19(3):175-178. [discussion: 175].
9. Butler P.C., Meier J.J., Butler A.E., et al. The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab 2007, 3(11):758-768.
10. Murtaugh L.C., Melton D.A. Genes, signals, and lineages in pancreas development. Annu Rev Cell Dev Biol 2003, 19:71-89.
11. Apelqvist A., Ahlgren U., Edlund H. Sonic Hedgehog directs specialised mesoderm differentiation in the intestine and pancreas. Curr Biol 1997, 7(10):801-804.
12. Hebrok M., Kim S.K., Melton D.A. Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev 1998, 12(11):1705-1713.
13. Edlund H. Transcribing pancreas. Diabetes 1998, 47(12):1817-1823.
14. Kim S.K., Hebrok M. Intercellular signals regulating pancreas development and function. Genes Dev 2001, 15(2):111-127.
15. Kim S.K., Hebrok M., Melton D.A. Notochord to endoderm signaling is required for pancreas development. Development 1997, 124(21):4243-4252.
16. Kim W., Shin Y.K., Kim B.J., et al. Notch signaling in pancreatic endocrine cell and diabetes. Biochem Biophys Res Commun 2010, 392(3):247-251.
17. Apelqvist A., Li H., Sommer L., et al. Notch signalling controls pancreatic cell differentiation. Nature 1999, 400(6747):877-881.
18. Gradwohl G., Dierich A., LeMeur M., et al. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A 2000, 97(4):1607-1611.
19. + cells are islet progenitors and are distinct from duct progenitors. Development 2002, 129(10):2447-2457.
20. Schwitzgebel V.M., Scheel D.W., Conners J.R., et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development 2000, 127(16):3533-3542.
21. Herrera P.L. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development 2000, 127(11):2317-2322.
22. Herrera P.L., Huarte J., Zufferey R., et al. Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenes. Proc Natl Acad Sci U S A 1994, 91(26):12999-13003.
23. Lee Y.C., Damholt A.B., Billestrup N., et al. Developmental expression of proprotein convertase 1/3 in the rat. Mol Cell Endocrinol 1999, 155(1-2):27-35.
24. Wilson M.E., Kalamaras J.A., German M.S. Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas. Mech Dev 2002, 115(1-2):171-176.
25. Guney M.A., Gannon M. Pancreas cell fate. Birth Defects Res C Embryo Today 2009, 87(3):232-248.
26. Collombat P., Hecksher-Sorensen J., Broccoli V., et al. The simultaneous loss of ARX and PAX4 genes promotes a somatostatin-producing cell fate specification at the expense of the alpha- and beta-cell lineages in the mouse endocrine pancreas. Development 2005, 132(13):2969-2980.
27. Collombat P., Hecksher-Sorensen J., Krull J., et al. Embryonic endocrine pancreas and mature beta cells acquire alpha and pp cell phenotypes upon ARX misexpression. J Clin Invest 2007, 117(4):961-970.
28. Collombat P., Mansouri A., Hecksher-Sorensen J., et al. Opposing actions of ARX and PAX4 in endocrine pancreas development. Genes Dev 2003, 17(20):2591-2603.
29. Ritz-Laser B., Estreicher A., Gauthier B.R., et al. The pancreatic beta-cell-specific transcription factor PAX-4 inhibits glucagon gene expression through PAX-6. Diabetologia 2002, 45(1):97-107.
30. Wang Q., Elghazi L., Martin S., et al. Ghrelin is a novel target of PAX4 in endocrine progenitors of the pancreas and duodenum. Dev Dyn 2008, 237(1):51-61.
31. Sussel L., Kalamaras J., Hartigan-O'Connor D.J., et al. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 1998, 125(12):2213-2221.
32. Fujimoto K., Polonsky K.S. Pdx1 and other factors that regulate pancreatic beta-cell survival. Diabetes Obes Metab 2009, 11(Suppl 4):30-37.
33. Taylor-Fishwick D.A., Shi W., Pittenger G.L., et al. Pdx-1 can repress stimulus-induced activation of the ingap promoter. J Endocrinol 2006, 188(3):611-621.
34. Ahlgren U., Jonsson J., Jonsson L., et al. Beta-cell-specific inactivation of the mouse ipf1/pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 1998, 12(12):1763-1768.
35. Dutta S., Bonner-Weir S., Montminy M., et al. Regulatory factor linked to late-onset diabetes?. Nature 1998, 392(6676):560.
36. Stoffers D.A., Stanojevic V., Habener J.F. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein. J Clin Invest 1998, 102(1):232-241.
37. Ohneda K., Mirmira R.G., Wang J., et al. The homeodomain of pdx-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter. Mol Cell Biol 2000, 20(3):900-911.
38. Gannon M., Ables E.T., Crawford L., et al. Pdx-1 function is specifically required in embryonic beta cells to generate appropriate numbers of endocrine cell types and maintain glucose homeostasis. Dev Biol 2008, 314(2):406-417.
39. Johansson K.A., Dursun U., Jordan N., et al. Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Dev Cell 2007, 12(3):457-465.
40. Mimeault M., Hauke R., Batra S.K. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 2007, 82(3):252-264.
41. Assady S., Maor G., Amit M., et al. Insulin production by human embryonic stem cells. Diabetes 2001, 50(8):1691-1697.
42. D'Amour K.A., Bang A.G., Eliazer S., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006, 24(11):1392-1401.
43. Segev H., Fishman B., Ziskind A., et al. Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 2004, 22(3):265-274.
44. Lumelsky N., Blondel O., Laeng P., et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001, 292(5520):1389-1394.
45. Hori Y., Rulifson I.C., Tsai B.C., et al. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A 2002, 99(25):16105-16110.
46. Hansson M., Tonning A., Frandsen U., et al. Artifactual insulin release from differentiated embryonic stem cells. Diabetes 2004, 53(10):2603-2609.
47. Rajagopal J., Anderson W.J., Kume S., et al. Insulin staining of ES cell progeny from insulin uptake. Science 2003, 299(5605):363.
48. Blyszczuk P., Czyz J., Kania G., et al. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci U S A 2003, 100(3):998-1003.
49. Lavon N., Yanuka O., Benvenisty N. The effect of overexpression of Pdx1 and Foxa2 on the differentiation of human embryonic stem cells into pancreatic cells. Stem Cells 2006, 24(8):1923-1930.
50. Miyazaki S., Yamato E., Miyazaki J. Regulated expression of Pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes 2004, 53(4):1030-1037.
51. Treff N.R., Vincent R.K., Budde M.L., et al. Differentiation of embryonic stem cells conditionally expressing neurogenin 3. Stem Cells 2006, 24(11):2529-2537.
52. Oliver-Krasinski J.M., Stoffers D.A. On the origin of the beta cell. Genes Dev 2008, 22(15):1998-2021.
53. Phillips B.W., Hentze H., Rust W.L., et al. Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage. Stem Cells Dev 2007, 16(4):561-578.
54. Jiang J., Au M., Lu K., et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 2007, 25(8):1940-1953.
55. D'Amour K.A., Agulnick A.D., Eliazer S., et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005, 23(12):1534-1541.
56. Kroon E., Martinson L.A., Kadoya K., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 2008, 26(4):443-452.
57. Yao S., Chen S., Clark J., et al. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci U S A 2006, 103(18):6907-6912.
58. Ballian N., Brunicardi F.C. Islet vasculature as a regulator of endocrine pancreas function. World J Surg 2007, 31(4):705-714.
59. Green R.M. Can we develop ethically universal embryonic stem-cell lines?. Nat Rev Genet 2007, 8(6):480-485.
60. Mauron A., Jaconi M.E. Stem cell science: current ethical and policy issues. Clin Pharmacol Ther 2007, 82(3):330-333.
61. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5):861-872.
62. Yu J., Vodyanik M.A., Smuga-Otto K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318(5858):1917-1920.
63. Meissner A., Wernig M., Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 2007, 25(10):1177-1181.
64. Park I.H., Zhao R., West J.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451(7175):141-146.
65. Kaji K., Norrby K., Paca A., et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458(7239):771-775.
66. Lin T., Ambasudhan R., Yuan X., et al. A chemical platform for improved induction of human ipscs. Nat Methods 2009, 6(11):805-808.
67. Woltjen K., Michael I.P., Mohseni P., et al. Piggybac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458(7239):766-770.
68. Stadtfeld M., Apostolou E., Akutsu H., et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010, 465(7295):175-181.
69. Dor Y., Brown J., Martinez O.I., et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004, 429(6987):41-46.
70. Brennand K., Huangfu D., Melton D. All beta cells contribute equally to islet growth and maintenance. PLoS Biol 2007, 5(7):e163.
71. Teta M., Rankin M.M., Long S.Y., et al. Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell 2007, 12(5):817-826.
72. Meier J.J., Butler A.E., Saisho Y., et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008, 57(6):1584-1594.
73. Teta M., Long S.Y., Wartschow L.M., et al. Very slow turnover of beta-cells in aged adult mice. Diabetes 2005, 54(9):2557-2567.
74. Zhou Q., Brown J., Kanarek A., et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008, 455(7213):627-632.
75. Lewaschew SW. Ueber eine eigenthiimliche Verinderung des Pancreaszellen warmbliutiger Thiere bei starker absonderungs- thiitigkeit der Driise. Archiv f Mikero Anat 1885; Bd.26, s:453-85.
76. Thorel F., Nepote V., Avril I., et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 2010, 464(7292):1149-1154.
77. Collombat P., Xu X., Ravassard P., et al. The ectopic expression of pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 2009, 138(3):449-462.
78. Laguesse E., de la Roche A.G. Les ilots de langerhans dans le pancreas du cobaye après ligature. C R Seances Soc Biol 1902, 54:854-857. [in French].
79. Bonner-Weir S., Inada A., Yatoh S., et al. Transdifferentiation of pancreatic ductal cells to endocrine beta-cells. Biochem Soc Trans 2008, 36(Pt 3):353-356.
80. Li M., Miyagawa J., Yamamoto K., et al. Beta cell neogenesis from ducts and phenotypic conversion of residual islet cells in the adult pancreas of glucose intolerant mice induced by selective alloxan perfusion. Endocrinol Jpn 2002, 49(5):561-572.
81. Pittenger GL, Taylor-Fishwick DA, Vinik AI. A role for islet neogenesis in curing diabetes. Diabetologia, 2009;52(5):735-8.
82. Rosenberg L., Lipsett M., Yoon J.W., et al. A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57bl/6j mice. Ann Surg 2004, 240(5):875-884.
83. Vinik A.I., Rosenberg L., Pittenger G.L., et al. Stimulation of pancreatic islet neogenesis: a possible treatment for type 1 and type 2 diabetes. Curr Opin Endocrinol Diabetes 2004, 11:125-140.
84. Xu X., D'Hoker J., Stange G., et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008, 132(2):197-207.
85. Rosenberg L., Vinik A.I., Pittenger G.L., et al. Islet-cell regeneration in the diabetic hamster pancreas with restoration of normoglycaemia can be induced by a local growth factor(s). Diabetologia 1996, 39(3):256-262.
86. Taylor-Fishwick D.A., Bowman A., Hamblet N., et al. Islet neogenesis associated protein transgenic mice are resistant to hyperglycemia induced by streptozotocin. J Endocrinol 2006, 190(3):729-737.
87. Pittenger G.L., Taylor-Fishwick D.A., Johns R.H., et al. Intramuscular injection of islet neogenesis-associated protein peptide stimulates pancreatic islet neogenesis in healthy dogs. Pancreas 2007, 34(1):103-111.
88. Fleming A., Rosenberg L. Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein. J Diabetes Sci Tech 2007, 1:231-244.
89. Dungan K.M., Buse J.B., Ratner R.E. Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP). Diabetes Metab Res Rev 2009, 25(6):558-565.
90. Hamblet N.S., Shi W., Vinik A.I., et al. The reg family member ingap is a marker of endocrine patterning in the embryonic pancreas. Pancreas 2008, 36(1):1-9.
91. Francini F., Del Zotto H., Massa M.L., et al. Selective effect of ingap-pp upon mouse embryonic stem cell differentiation toward islet cells. Regul Pept 2009, 153(1-3):43-48.
92. Flint A., Raben A., Astrup A., et al. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998, 101(3):515-520.
93. Nauck M.A., Wollschlager D., Werner J., et al. Effects of subcutaneous glucagon-like peptide 1 (glp-1 [7-36 amide]) in patients with niddm. Diabetologia 1996, 39(12):1546-1553.
94. Larsson H., Holst J.J., Ahren B. Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans. Acta Physiol Scand 1997, 160(4):413-422.
95. Drucker D.J. Glucagon-like peptides. Diabetes 1998, 47(2):159-169.
96. Tourrel C., Bailbe D., Lacorne M., et al. Persistent improvement of type 2 diabetes in the goto-kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 2002, 51(5):1443-1452.
97. Brand S.J., Tagerud S., Lambert P., et al. Pharmacological treatment of chronic diabetes by stimulating pancreatic beta-cell regeneration with systemic co-administration of EGF and gastrin. Pharmacol Toxicol 2002, 91(6):414-420.
98. Ghofaili K.A., Fung M., Ao Z., et al. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes. Transplantation 2007, 83(1):24-28.
99. Brand S.J., Fuller P.J. Differential gastrin gene expression in rat gastrointestinal tract and pancreas during neonatal development. J Biol Chem 1988, 263(11):5341-5347.
100. Suarez-Pinzon W.L., Lakey J.R., Brand S.J., et al. Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass. J Clin Endocrinol Metab 2005, 90(6):3401-3409.